Literature DB >> 28282630

Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.

Rebecca McKetin1, Amanda L Baker2, Sharon Dawe3, Alexandra Voce4, Dan I Lubman5.   

Abstract

We examined the lifetime experience of hallucinations and delusions associated with transient methamphetamine-related psychosis (MAP), persistent MAP and primary psychosis among a cohort of dependent methamphetamine users. Participants were classified as having (a) no current psychotic symptoms, (n=110); (b) psychotic symptoms only when using methamphetamine (transient MAP, n=85); (c) psychotic symptoms both when using methamphetamine and when abstaining from methamphetamine (persistent MAP, n=37), or (d) meeting DSM-IV criteria for lifetime schizophrenia or mania (primary psychosis, n=52). Current psychotic symptoms were classified as a score of 4 or more on any of the Brief Psychiatric Rating Scale items of suspiciousness, hallucinations or unusual thought content in the past month. Lifetime psychotic diagnoses and symptoms were assessed using the Composite International Diagnostic Interview. Transient MAP was associated with persecutory delusions and tactile hallucinations (compared to the no symptom group). Persistent MAP was additionally associated with delusions of reference, thought interference and complex auditory, visual, olfactory and tactile hallucinations, while primary psychosis was also associated with delusions of thought projection, erotomania and passivity. The presence of non-persecutory delusions and hallucinations across various modalities is a marker for persistent MAP or primary psychosis in people who use methamphetamine.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Amphetamine; Amphetamine-related disorders; Central nervous system stimulants; Hallucinations; Paranoia; Psychotic disorders; Street drugs

Mesh:

Substances:

Year:  2017        PMID: 28282630     DOI: 10.1016/j.psychres.2017.02.028

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

2.  An evolutionary perspective on paranoia.

Authors:  Nichola J Raihani; Vaughan Bell
Journal:  Nat Hum Behav       Date:  2018-12-17

3.  Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.

Authors:  Yanhong Zhang; Guofang Shu; Ying Bai; Jie Chao; Xufeng Chen; Honghong Yao
Journal:  Metab Brain Dis       Date:  2018-06-26       Impact factor: 3.584

4.  Methamphetamine-Induced Cognitive Deficits and Psychiatric Symptoms Are Associated with Serum Markers of Liver Damage.

Authors:  Tingting Zhao; Changping Zhai; Hongmei Song; Yanhai Wu; Chuanhui Ge; Yonglin Zhang; Hongxia Xu; Zhengsuo Chi; Hui Chu; Wei Shi; Xiaodong Cheng; Xin Li; Mengdi Ma; Mengyuan Xu; Jiaqi Hu; Ya Xie; Yanan Lin; Hongxu Chen; Yiting Li; Dongliang Jiao
Journal:  Neurotox Res       Date:  2019-11-05       Impact factor: 3.911

5.  Occurrence and phenomenology of hallucinations in the general population: A large online survey.

Authors:  Mascha M J Linszen; Janna N de Boer; Maya J L Schutte; Marieke J H Begemann; Jacqueline de Vries; Sanne Koops; Renske E Blom; Marc M Bohlken; Sophie M Heringa; Jan Dirk Blom; Iris E C Sommer
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-23

Review 6.  Dementia-related psychosis and the potential role for pimavanserin.

Authors:  Jeffery L Cummings; D P Devanand; Stephen M Stahl
Journal:  CNS Spectr       Date:  2020-08-19       Impact factor: 3.790

7.  Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?

Authors:  Rebecca McKetin; Alexandra Voce; Richard Burns; Robert Ali; Dan I Lubman; Amanda L Baker; David J Castle
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

Review 8.  Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research.

Authors:  Alexandre A Guerin; Yvonne Bonomo; Andrew John Lawrence; Bernhard Theodor Baune; Eric J Nestler; Susan L Rossell; Jee Hyun Kim
Journal:  Front Psychiatry       Date:  2019-12-17       Impact factor: 4.157

9.  Prevalence and predictors of recent temporary psychiatric hold among a cohort of people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Kelsey A Simpson; Hrant Gevorgian; Alex H Kral; Lynn Wenger; Philippe Bourgois; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

Review 10.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.